Evidence map›Paper›PMID 32038722›Full record

ArticleFrontiers in genetics2019

Comprehensive Analysis of Copy Number Variations in Kidney Cancer by Single-Cell Exome Sequencing.

Wenyang Zhou, Fan Yang, Zhaochun Xu, Meng Luo, Pingping Wang, Yu Guo, Huan Nie, Lifen Yao, Qinghua Jiang

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.1field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Wenyang ZhouSchool of Life Science and Technology, Harbin Institute of Technology, Harbin, China.
Fan YangDepartment of Neurology, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
Zhaochun XuSchool of Life Science and Technology, Harbin Institute of Technology, Harbin, China.
Meng LuoSchool of Life Science and Technology, Harbin Institute of Technology, Harbin, China.
Pingping WangSchool of Life Science and Technology, Harbin Institute of Technology, Harbin, China.
Yu GuoSchool of Life Science and Technology, Harbin Institute of Technology, Harbin, China.
Huan NieSchool of Life Science and Technology, Harbin Institute of Technology, Harbin, China.
Lifen YaoDepartment of Neurology, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
Qinghua JiangSchool of Life Science and Technology, Harbin Institute of Technology, Harbin, China.
Harbin Institute of Technology · CNHarbin Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Clear-cell renal cell carcinoma (ccRCC) is the most common and lethal subtype of kidney cancer.

Indexed as

clear-cell renal cell carcinomacopy number variationsreceptor protein tyrosine kinasesignaling transduction pathwaysingle-cell exome sequencing

Identifiers

PMID32038722
PMCPMC6989475
OpenAlexW3002917508

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.